PATENT CLAIM ANALYSIS

Application Number: 16022019
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "063000"]

Abstract:
Augmented or synergized anti-inflammatory constructs are disclosed including anti-inflammatory amino acids covalently conjugated with other anti-inflammatory molecules such as nonsteroidal anti-inflammatory drugs, vanilloids and ketone bodies. Further conjugation with a choline bioisostere or an additional anti-inflammatory moiety further augments the anti-inflammatory activity.

Claim (Index 46):
The anti-inflammatory drug\u2014amino acid conjugate of  claim 44 , wherein said conjugate is

Metadata:
- Claim Count in Document: 26.0
- Percentile: 94.0
- Lexical Diversity: 1.21622
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14776857', '14409612', '12706735', '13582487', '13422565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7449106557045917
- 35 USC 102 Novelty (BERT): 0.5687835298975606
- Combined Prediction Score: 0.7272979431238886
- Mean Citation Score: 292.253476
- Max Citation Score: 500.34738
- Similarity Product: 299.52364356373783

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test